Association of atopic dermatitis with allergic, autoimmune, and cardiovascular comorbidities in US adults
Cited by (0)
Disclosures: Dr Silverberg served as a consultant and/or advisory board member for and received honoraria from Abbvie, Asana, Eli Lilly, Galderma, GlaxoSmithKline, Glenmark, Kiniksa, Leo, Menlo, Pfizer, Regeneron-Sanofi, Realm, and Roivant; was a speaker for Regeneron-Sanofi; received research grants from GlaxoSmithKline and Regeneron-Sanofi; and is supported by the Dermatology Foundation. Dr Gelfand served as a consultant for and received honoraria from BMS, Boehringer Ingelheim, GSK, Janssen Biologics, Menlo Therapeutics, Novartis Corp, Regeneron, Dr Reddy's Labs, UCB (DSMB), Sanofi, and Pfizer Inc; receives research grants (to the Trustees of the University of Pennsylvania) from Abbvie, Janssen, Novartis Corp, Sanofi, Celgene, Ortho Dermatologics, and Pfizer Inc; received payment for continuing medical education work related to psoriasis that was supported indirectly by Lilly and Ortho Dermatologics; is a co-patent holder of resiquimod for treatment of cutaneous T-cell lymphoma; is a Deputy Editor for the Journal of Investigative Dermatology and receives honoraria from the Society for Investigative Dermatology; and is supported by NIH/NIAMS K24-AR064310. Dr Chiesa Fuxench has served as a consultant for and received honoraria from the National Eczema Association and the Asthma and Allergy Foundation; receives or has received research grants (to the Trustees of the University of Pennsylvania) from Regeneron, Sanofi, Tioga, Vanda, and Realm Therapeutics for work in atopic dermatitis; and has received payment for continuing medical education work related to atopic dermatitis that was supported indirectly by Regeneron and/or Sanofi. Dr Margolis is the chair of the data monitoring committee for all Sunovion clinical trials of dupilamab and has received independent research funding to his institution from the National Institute of Health and Valeant. Dr Boguniewicz has received research funding from Anacor and Regeneron and consulted for Regeneron, Sanofi-Genzyme, and Pfizer. Dr Fonacier has served as a consultant for and received honoraria from Regeneron; is speaker for Regeneron; and received research and educational grants from Genentech, Baxter, and Pfizer. Dr Grayson is a board member of the AAFA and chair of the AAFA Medical Scientific Council. Dr Simpson has served as a consultant and/or advisory board member for Regeneron-Sanofi.
Funding Sources: The Atopic Dermatitis in America Study is an independent research project of the Asthma and Allergy Foundation of America in partnership with the National Eczema Association and is sponsored by Sanofi, Genzyme, and Regeneron.